Table 1.
Baseline characteristics of the patients included in the study
| Male | 25 (58%) |
| Age (years) | 35 ± 13 |
| Age > 65 years | 0 |
| Hypertension | 0 |
| Smoke | 18 (42%) |
| Dyslipidemia | 4 (9%) |
| Family history of heart disease | 8 (19%) |
| Chronic kidney disease | 0 |
| Mediastinal RT (non-cardiac field) | 6 (14%) |
| Doxorubicin dose (mg/m2) | 251 ± 57 |
| ECHOPRE | 26 (60%) |
| LVEDD (mm) | 47.2 ± 5.2 |
| LVESD (mm) | 28.2 ± 3.9 |
| LVEF (%) | 70.3 ± 7.1 |
RT: radiotherapy; ECHOPRE: baseline echocardiography; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEF: left ventricular ejection fraction